X4 Pharmaceuticals (XFOR) Change in Acquisitions & Divestments (2023 - 2025)
X4 Pharmaceuticals' (XFOR) quarterly Change in Acquisitions & Divestments came in at $18.8 million in Q4 2025, up 32.04% YoY from $14.2 million in Q4 2024, and up 18.18% on a QoQ basis from $15.9 million in Q3 2025.
X4 Pharmaceuticals (XFOR) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $18.8 million in Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 32.04% year-over-year to $18.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $74.5 million (up 181.82% YoY) and the FY2025 annual result came in at $74.5 million, up 181.82% from the prior year.
- Change in Acquisitions & Divestments grew to $18.8 million in Q4 2025, from $15.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $28.2 million in Q2 2025 to a low of $1.0 million in Q3 2023.
- A 3-year average of $10.3 million and a median of $8.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 1320.0% — and 2025, when it soared 32.04%.
- Tracing XFOR's Change in Acquisitions & Divestments over 3 years: stood at $1.0 million in 2023, then jumped by 1320.0% to $14.2 million in 2024, then jumped by 32.04% to $18.8 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $18.8 million (Q4 2025), $15.9 million (Q3 2025), and $28.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.75 Mn |
| Dec 31, 2025 | 18.75 Mn |
| Sep 30, 2025 | 15.87 Mn |
| Sep 30, 2025 | 15.87 Mn |
| Jun 30, 2025 | 28.18 Mn |
| Jun 30, 2025 | 28.18 Mn |
| Mar 31, 2025 | 11.75 Mn |
| Mar 31, 2025 | 11.75 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |